Anthropometric measures and cognition in middle-aged HIV-infected and uninfected women. the Women's Interagency HIV Study

Journal of NeuroVirology

Volumn 19, Issue 6, 2013, Pages 574-585

  Gustafson, Deborah R ^a,b   Mielke, Michelle M ^c   Tien, Phyllis C ^c   Valcour, Victor ^c,d   Cohen, Mardge ^e,f   Anastos, Kathryn ^g   Liu, Chenglong ^h   Pearce, Leigh ⁱ   Golub, Elizabeth T ^j   Minkoff, Howard ^k,l   Crystal, Howard A ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Department of Ambulatory and Community Health   (United States)

^f RUSH MEDICAL COLLEGE   (United States)

^g ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^h GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^j JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^k Maimonides Hospital   (United States)

^l Downstate Health Sciences University   (United States)

more..

Author keywords

Cognition; HIV; Middle aged; Obesity; Overweight; Women

Indexed keywords

ADULT; AGE DISTRIBUTION; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CD4 LYMPHOCYTE COUNT; COGNITION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EXECUTIVE FUNCTION; EXPERIMENTAL COGNITIVE TEST; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMATION PROCESSING; LEARNING AND MEMORY TEST; MAJOR CLINICAL STUDY; MENTAL PERFORMANCE; MIDDLE AGED; OBESITY; PRIORITY JOURNAL; READING; STROOP TEST; WAIST CIRCUMFERENCE; WAIST HIP RATIO; WIDE RANGE ACHIEVEMENT TEST; WORD RECOGNITION;

ADULT; AGE FACTORS; BODY MASS INDEX; CASE-CONTROL STUDIES; COGNITION; COGNITION DISORDERS; EXECUTIVE FUNCTION; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TASK PERFORMANCE AND ANALYSIS; WAIST CIRCUMFERENCE; WAIST-HIP RATIO;

EID: 84891478587     PISSN: 13550284     EISSN: 15382443     Source Type: Journal    
DOI: 10.1007/s13365-013-0219-1     Document Type: Article

References (39)

1. Andrieu S, Aboderin I, Baeyens JP, Beard J, Benetos A, Berrut G, Brainin M, Cha HB, Chen LK, Du P, Forette B, Forette F, Franco A, Fratiglioni L, Gilette-Guyonnet S, Gold G, Gomez F, Guimaraes R, Gustafson D (2011) IAGG workshop: health promotion program on prevention of late onset dementia. J Nutr Health Aging 15:562-575
2. Bacon MC, von Wyl V, Alden C, Sharp G, Robison E, Hessol N, Gange S, Barranday Y, Holman S, Weber K, Young MA (2005) The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench. Clin Diagn Lab Immunol 12:1013-1019
3. Barkan SE, Melnick SL, Preston-Martin S, Weber K, Kalish LA, Miotti P, Young M, Greenblatt R, Sacks H, Feldman J (1998) The Women's Interagency HIV Study. WIHS Collaborative Study Group. Epidemiology 9:117-125
4. Becker JT, Kingsley L, Mullen J, Cohen B, Martin E, Miller EN, Ragin A, Sacktor N, Selnes OA, Visscher BR (2009) Vascular risk factors, HIV serostatus, and cognitive dysfunction in gay and bisexual men. Neurology 73:1292-1299
5. Berger JR, Brew B (2005) An international screening tool for HIV dementia. AIDS 19:2165
6. Bhaskaran K, Mussini C, Antinori A et al (2008) Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy. Ann Neurol 63:213
7. Bozzette SA, Ake CF, Tam HK, Chang SW, Louis TA (2003) Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection. N Engl J Med 348:702-710
8. Capeau J, Bouteloup V, Katlama C, Bastard JP, Guiyedi V, Salmon-Ceron D, Protopopescu C, Leport C, Raffi F, Chene G (2012) Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment. AIDS 26:303-314
9. Centers for Disease Control and Prevention (2012a) Estimated HIV incidence among adults and adolescents in the United States, 2007-2010
10. Centers for Disease Control and Prevention (2012b) Monitoring selected national HIV prevention and care objectives by using HIV surveillance data - United States and 6 U.S. dependent areas - 2010. HIV Surveillance Supplemental Report 2012. Centers for Disease Control and Prevention: Atlanta
11. Cohen RA, Gongvatana A (2010) The persistence of HIV-associated neurocognitive dysfunction and the effects of comorbidities. Neurology 75:2052-2053
12. Croft JB, Keenan NL, Sheridan DP, Wheeler FC, Speers MA (1995) Waist-to-hip ratio in a biracial population: measurement, implications, and cautions for using guidelines to define high risk for cardiovascular disease. J Am Diet Assoc 95:60-64
13. Crystal HA, Weedon J, Holman S, Manly J, Valcour V, Cohen M, Anastos K, Liu C, Mack WJ, Golub E, Lazar J, Ho A, Kreek MJ, Kaplan RC (2011) Associations of cardiovascular variables and HAART with cognition in middle-aged HIV-infected and uninfected women. J Neurovirol 17:469-476
14. Currier J (2007) Report from the 14th Retrovirus Conference. Metabolic complications: lipoatrophy, lipohypertrophy, and cardiovascular risk. AIDS Clin Care 19:40-41
15. Fitzpatrick AL, Kuller LH, Lopez OL, Diehr P, O'Meara ES, Longstreth WT Jr, Luchsinger JA (2009) Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Arch Neurol 66:336-342
16. González-Scarano F, Martín'García J (2005) The neuropathogenesis of AIDS. Nat Rev Immunol 5:69
17. Gustafson DR (2010) Adiposity hormones and dementia. J Neurosci 299:30-34
18. Gustafson D, Skoog I (2009) Control of vascular risk factors. In: L-O Wahlund TE, Gauthier S (eds) Vascular dementia in clinical practice. Cambridge University Press, London
19. Gustafson DR, Bäckman K, Waern M, Östling S, Guo X, Zandi PP, Mielke MM, Bengtsson C, Skoog I (2009a) Adiposity indicators and dementia over 32 years in Sweden. Neurology 73:1559-1566
20. Gustafson DR, Bäckman K, Waern M, Östling S, Guo XX, Zandi P, Mielke MM, Bengtsson C, Skoog I (2009b) Adiposity indicators and dementia over 32 years in Sweden. Neurology 73:1559-1566
21. Heaton RK, Clifford DB, Franklin DR Jr, Woods SP, Ake C, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH, Rivera-Mindt M, Vigil OR, Taylor MJ, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 75:2087-2096
22. Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, Leblanc S, Corkran SH, Duarte NA, Clifford DB, Woods SP, Collier AC, Marra CM, Morgello S, Mindt MR, Taylor MJ, Marcotte TD, Atkinson JH, Wolfson T, Gelman BB, McArthur JC, Simpson DM, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I (2011) HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol 17:3-16
23. Justman JE, Hoover DR, Shi Q, Tan T, Anastos K, Tien PC, Cole SR, Hyman C, Karim R, Weber K, Grinspoon S (2008) Longitudinal anthropometric patterns among HIV-infected and HIV-uninfected women. J Acquir Immune Defic Syndr 47:312-319
24. Kaplan RC, Kingsley LA, Gange SJ, Benning L, Jacobson LP, Lazar J, Anastos K, Tien PC, Sharrett AR, Hodis HN (2008) Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men. AIDS 22:1615-1624
25. Kivipelto M, Ngandu T, Fratiglioni L, Viitanen M, Kareholt I, Winblad B, Helkala EL, Tuomilehto J, Soininen H, Nissinen A (2005) Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol 62:1556-1560
26. Mansoor A, Althoff K, Gange S, Anastos K, Dehovitz J, Minkoff H, Kaplan R, Holman S, Lazar JM (2009) Elevated NT-pro-BNP levels are associated with comorbidities among HIV-infected women. AIDS Res Hum Retrovir 25:997-1004
27. Mary-Krause M, Cotte L, Simon A, Partisani M, Costagliola D (2003) Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men. AIDS 17:2479-2486
28. McArthur JC, Brew BJ (2010) HIV-associated neurocognitive disorders: is there a hidden epidemic? AIDS 24:1367-1370
29. McCutchan JA, Marquie-Beck JA, Fitzsimons CA, Letendre SL, Ellis RJ, Heaton RK, Wolfson T, Rosario D, Alexander TJ, Marra C, Ances BM, Grant I (2012) Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder. Neurology 78:485-492
30. Miller EN, Selnes OA, McArthur JC, Satz P, Becker JT, Cohen BA, Sheridan K, Machado AM, Van Gorp WG, Visscher B (1990) Neuropsychological performance in HIV-1-infected homosexual men: The Multicenter AIDS Cohort Study (MACS). Neurology 40:197-203
31. Moroni M, Antinoria S (2003) HIV and direct damage of organs: disease spectrum before and during the highly active antiretroviral therapy era. AIDS 17:S51
32. Robertson KR, Su Z, Margolis DM, Krambrink A, Havlir DV, Evans S, Skiest DJ (2010) Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort. Neurology 74:1260-1266
33. Saktor N (2002) The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. J Neurovirol 8:115
34. Shah N, Braverman ER (2012) Measuring adiposity in patients: the utility of body mass index (BMI), percent body fat, and leptin. PLOS One 7:e33308
35. Sobieszczyk ME, Hoover DR, Anastos K, Mulligan K, Tan T, Shi Q, Gao W, Hyman C, Cohen MH, Cole SR, Plankey MW, Levine AM, Justman J (2008) Prevalence and predictors of metabolic syndrome among HIV-infected and HIV-uninfected women in the Women's Interagency HIV Study. J Acquir Immune Defic Syndr 48:272-280
36. Whitmer RA, Gunderson EP, Barrett-Connor E, Quesenberry CP Jr, Yaffe K (2005) Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. BMJ 330:1360-1364
37. Whitmer RA, Gunderson EP, Quesenberry CP Jr, Zhou J, Yaffe K (2007) Body mass index in midlife and risk of Alzheimer disease and vascular dementia. Curr Alzheim Res 4:103-109
38. Whitmer RA, Gustafson DR, Barrett-Connor E, Haan MN, Gunderson EP, Yaffe K (2008) Central obesity and increased risk of dementia more than three decades later. Neurology 71:1057-1064
39. Wright EJ, Grund B, Robertson K, Brew BJ, Roediger M, Bain MP, Drummond F, Vjecha MJ, Hoy J, Miller C, Penalva de Oliveira AC, Pumpradit W, Shlay JC, El-Sadr W, Price RW (2010) Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons. Neurology 75:864-873